Search Results for: Neothetics Announces Last Subject Enrolled
Articles
March 27, 2017
Neothetics Announces Last Subject Enrolled in Phase II Trial March 27, 2017
Neothetics, Inc. recently announced completion of subject enrollment for its Phase II proof-of-concept trial, LIPO-202-CL-31, for the reduction of submental...
